A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma (5-AZ)
Sponsor and Collaborators
University of Kansas
Celgene Corporation
Contact
Peter J Van Veldhuizen, MD
913-588-6029
pvanveldhuizen@kumc.edu
Principal Investigator
Peter J Van Veldhuizen, MD
University of Kansas
ClinicalTrials.gov Identifier
NCT00934440